These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 5731801

  • 1. Allopurinol and the control of hyperuricemia in neoplastic disease.
    Med Lett Drugs Ther; 1968 Dec 13; 10(25):103-4. PubMed ID: 5731801
    [No Abstract] [Full Text] [Related]

  • 2. Hyperuricemia complicating acute leukemia. Case reports and comments on therapy.
    al-Rashid RA, Call JE.
    Clin Pediatr (Phila); 1970 Apr 13; 9(4):203-5. PubMed ID: 5441843
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Life-threatening hyperuricemia during cytostatic leukemia therapy].
    Schwenk HU, Schneider U.
    Fortschr Med; 1982 Mar 18; 100(11):454-8. PubMed ID: 6951795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Allopurinol in the treatment of neoplastic disease complicated by hyperuricemia.
    Muggia FM, Ball TJ, Ultmann JE.
    Arch Intern Med; 1967 Jul 18; 120(1):12-8. PubMed ID: 6028692
    [No Abstract] [Full Text] [Related]

  • 11. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.
    Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369
    [Abstract] [Full Text] [Related]

  • 12. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W, Walter-Sack I, de Vries JX.
    Eur J Med Res; 1998 Feb 21; 3(1-2):77-80. PubMed ID: 9512972
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy with 6-mercaptopurine (NSC-755) and allopurinol (NSC-1390) during induction and maintenance of remission of acute leukemia in children.
    Levine AS, Sharp HL, Mitchell J, Krivit W, Nesbit ME.
    Cancer Chemother Rep; 1969 Feb 21; 53(1):53-7. PubMed ID: 5772655
    [No Abstract] [Full Text] [Related]

  • 14. [Hyperuricemia caused by cytostatic drugs and treated with Milurit].
    Demény P.
    Orv Hetil; 1973 Feb 18; 114(7):384-6. PubMed ID: 4510204
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of allopurinol on the pharmacokinetics of 6-mercaptopurine (NSC 755) in cancer patients.
    Coffey JJ, White CA, Lesk AB, Rogers WI, Serpick AA.
    Cancer Res; 1972 Jun 18; 32(6):1283-9. PubMed ID: 5030828
    [No Abstract] [Full Text] [Related]

  • 17. [Our experience in the treatment of hyperuricemia with a xanthine oxidase inhibitor (HPP), Allopurinol].
    Rapado Errazti A.
    Rev Esp Reum Enferm Osteoartic; 1966 Oct 18; 11(8):304-6. PubMed ID: 5997999
    [No Abstract] [Full Text] [Related]

  • 18. [Antiblastic therapy and cytolysis in infantile leukemia].
    Masera G, Carnelli V, Corbella E, Uderzo C.
    Minerva Med; 1975 Jul 28; 66(52):2597-604. PubMed ID: 1153115
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Hypocalcemia and hyperuricemia during treatment of acute lymphoblastic leukemia in childhood].
    Armata J, Depowska T.
    Pol Tyg Lek; 1974 Jul 29; 29(30):1309-10. PubMed ID: 4527390
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.